D-Index & Metrics Best Publications
Microbiology
Canada
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 80 Citations 19,640 332 World Ranking 322 National Ranking 10
Medicine D-index 94 Citations 28,420 486 World Ranking 5014 National Ranking 214

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Canada Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Harry L.A. Janssen spends much of his time researching Internal medicine, Gastroenterology, Immunology, Hepatitis B and Hepatitis B virus. The concepts of his Internal medicine study are interwoven with issues in Entecavir and Surgery. His Surgery research incorporates elements of Odds ratio and Hazard ratio.

His study in Gastroenterology is interdisciplinary in nature, drawing from both Lamivudine, Liver transplantation, Budd–Chiari syndrome and Cohort. His Immunology study combines topics in areas such as Natural killer cell and Virology. His research integrates issues of HBsAg, HBeAg, Randomized controlled trial, Hepatitis and Pharmacotherapy in his study of Hepatitis B.

His most cited work include:

  • The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases (272 citations)
  • Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome (265 citations)
  • Suicide associated with alfa-interferon therapy for chronic viral hepatitis (256 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Gastroenterology, Immunology, Hepatitis B virus and Hepatitis B. His biological study spans a wide range of topics, including Chronic hepatitis, HBsAg, HBeAg and Entecavir. His Gastroenterology research includes elements of Pegylated interferon, Hepatocellular carcinoma, Surgery and Hazard ratio.

As part of his studies on Immunology, he frequently links adjacent subjects like Virology. His Hepatitis B virus study integrates concerns from other disciplines, such as Viral hepatitis, Interferon, Alpha interferon and Genotype. His Hepatitis B study combines topics from a wide range of disciplines, such as Lamivudine, Adefovir, Hepatology and Hepatitis.

He most often published in these fields:

  • Internal medicine (73.19%)
  • Gastroenterology (53.15%)
  • Immunology (44.01%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (73.19%)
  • Gastroenterology (53.15%)
  • Hepatitis B virus (32.49%)

In recent papers he was focusing on the following fields of study:

Internal medicine, Gastroenterology, Hepatitis B virus, Hepatitis B and HBeAg are his primary areas of study. Harry L.A. Janssen has included themes like HBsAg and Chronic hepatitis in his Internal medicine study. The various areas that Harry L.A. Janssen examines in his Gastroenterology study include Entecavir, Liver transplantation, Randomized controlled trial and Hazard ratio.

The Hepatitis B virus portion of his research involves studies in Immunology and Virology. His work in Immunology addresses issues such as Peripheral blood mononuclear cell, which are connected to fields such as Interferon. His research in Hepatitis B intersects with topics in Liver disease, Peginterferon alfa-2a and Virus.

Between 2017 and 2021, his most popular works were:

  • Hepatitis B virus infection (141 citations)
  • A global scientific strategy to cure hepatitis B (119 citations)
  • 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection (113 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Harry L.A. Janssen mainly investigates Internal medicine, Gastroenterology, Hepatitis B virus, Cirrhosis and Hepatocellular carcinoma. His Internal medicine research is multidisciplinary, incorporating elements of Entecavir and HBeAg. The concepts of his Gastroenterology study are interwoven with issues in Viral hepatitis, Chronic hepatitis, Randomized controlled trial and Hazard ratio.

His Hepatitis B virus research is mostly focused on the topic HBsAg. His HBsAg research is classified as research in Immunology. Harry L.A. Janssen has researched Hepatocellular carcinoma in several fields, including Microarray, Cohort study and Hepatitis C virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis. A report on 241 cases

Jean-Jacques Kiladjian;Francisco Cervantes;Franck W. G. Leebeek;Christophe Marzac.
Blood (2008)

413 Citations

Suicide associated with alfa-interferon therapy for chronic viral hepatitis

Harry L.A. Janssen;Johannes T. Brouwer;Rose C. van der Mast;Solko W. Schalm.
Journal of Hepatology (1994)

393 Citations

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth.
Journal of Hepatology (2011)

393 Citations

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline.

Milan J. Sonneveld;Vincent Rijckborst;Charles A. B. Boucher;Bettina E. Hansen.
Hepatology (2010)

387 Citations

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

Renate G. van der Molen;Dave Sprengers;Rekha S. Binda;Esther C. de Jong.
Hepatology (2004)

363 Citations

Treatment with Peg-interferon alpha-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype.

Hajo J. Flink;Monika Van Zonneveld;Bettina E. Hansen;Robert A. De Man.
The American Journal of Gastroenterology (2006)

350 Citations

Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome

Sarwa Darwish Murad;Dominique Charles Valla;Piet C. De Groen;Guy Zeitoun.
Hepatology (2004)

347 Citations

Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy

George V. Papatheodoridis;Henry Lik Yuen Chan;Bettina E. Hansen;Harry L A Janssen;Harry L A Janssen.
Journal of Hepatology (2015)

337 Citations

Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen.
Gastroenterology (2014)

332 Citations

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.

Bart J. Veldt;Wendong Chen;E. Jenny Heathcote;Heiner Wedemeyer.
Hepatology (2008)

324 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Harry L.A. Janssen

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 116

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 86

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 79

Sang Hoon Ahn

Sang Hoon Ahn

Yonsei University

Publications: 74

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 71

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 67

Ton Lisman

Ton Lisman

University Medical Center Groningen

Publications: 64

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 63

Grace Lai-Hung Wong

Grace Lai-Hung Wong

Chinese University of Hong Kong

Publications: 61

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 60

Dominique Valla

Dominique Valla

Université Paris Cité

Publications: 57

Bettina E. Hansen

Bettina E. Hansen

University Health Network

Publications: 55

Kwang Hyub Han

Kwang Hyub Han

Yonsei University

Publications: 53

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 53

Markus Cornberg

Markus Cornberg

Hannover Medical School

Publications: 52

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 52

Trending Scientists

Jonathan H. Connell

Jonathan H. Connell

IBM (United States)

Søren Johansen

Søren Johansen

University of Copenhagen

Daniel J. Rosenkrantz

Daniel J. Rosenkrantz

University of Virginia

Alberte Pullman

Alberte Pullman

Université Paris Cité

Jiayin Yuan

Jiayin Yuan

Stockholm University

Kaibin Tang

Kaibin Tang

University of Science and Technology of China

Harald Ibach

Harald Ibach

Forschungszentrum Jülich

Michael L. Rosenzweig

Michael L. Rosenzweig

University of Arizona

Zlatko Dembic

Zlatko Dembic

University of Oslo

Brian H. Anderton

Brian H. Anderton

King's College London

Timothy A. Reinhardt

Timothy A. Reinhardt

Agricultural Research Service

Fred Sinowatz

Fred Sinowatz

Ludwig-Maximilians-Universität München

Francesco Villani

Francesco Villani

University of Naples Federico II

Emmanouil N. Anagnostou

Emmanouil N. Anagnostou

University of Connecticut

Paul J. Thuluvath

Paul J. Thuluvath

Mercy Medical Center

Xavier Leleu

Xavier Leleu

Harvard University

Something went wrong. Please try again later.